Recent advances in neuroscience have revealed unprecedented insights into how psilocybin, the psychoactive compound in magic mushrooms, induces therapeutic neural plasticity. This paper reviews groundbreaking research conducted by Cornell University and the Allen Institute for Brain Science, which employed genetically modified rabies virus for monosynaptic circuit tracing to map brain-wide connectivity changes following psilocybin administration. Using this innovative methodology, researchers discovered that psilocybin triggers network-specific neural rewiring that is activity-dependent and programmable. The study demonstrates that psilocybin strengthens sensory-motor pathways while weakening cortical-cortical feedback loops associated with rumination and depression. Statistical analysis revealed highly significant, non-random patterns of synaptic reorganization (p = 6 × 10⁻⁵), with sensory regions showing up to 10% increases in connectivity and self-referential regions exhibiting up to 15% decreases. Critically, neural activity during the psilocybin window determines which circuits are strengthened or weakened, suggesting therapeutic interventions could be optimized by controlling sensory and cognitive experiences during treatment. These findings provide mechanistic insights into psilocybin’s rapid antidepressant effects and establish a foundation for precision psychedelic therapeutics.
Zen Revista (2026) studied this question.